Cargando…

Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting

Detalles Bibliográficos
Autores principales: Abdullahi, Adam, Fopoussi, Olga Mafotsing, Torimiro, Judith, Atkins, Mark, Kouanfack, Charles, Geretti, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446136/
https://www.ncbi.nlm.nih.gov/pubmed/30968060
http://dx.doi.org/10.1093/ofid/ofz142
_version_ 1783408306476285952
author Abdullahi, Adam
Fopoussi, Olga Mafotsing
Torimiro, Judith
Atkins, Mark
Kouanfack, Charles
Geretti, Anna Maria
author_facet Abdullahi, Adam
Fopoussi, Olga Mafotsing
Torimiro, Judith
Atkins, Mark
Kouanfack, Charles
Geretti, Anna Maria
author_sort Abdullahi, Adam
collection PubMed
description
format Online
Article
Text
id pubmed-6446136
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-64461362019-04-09 Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting Abdullahi, Adam Fopoussi, Olga Mafotsing Torimiro, Judith Atkins, Mark Kouanfack, Charles Geretti, Anna Maria Open Forum Infect Dis Corrigendum Oxford University Press 2019-04-03 /pmc/articles/PMC6446136/ /pubmed/30968060 http://dx.doi.org/10.1093/ofid/ofz142 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Abdullahi, Adam
Fopoussi, Olga Mafotsing
Torimiro, Judith
Atkins, Mark
Kouanfack, Charles
Geretti, Anna Maria
Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting
title Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting
title_full Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting
title_fullStr Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting
title_full_unstemmed Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting
title_short Corrigendum: Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting
title_sort corrigendum: hepatitis b virus (hbv) infection and re-activation during nucleos(t)ide reverse transcriptase inhibitor–sparing antiretroviral therapy in a high–hbv endemicity setting
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446136/
https://www.ncbi.nlm.nih.gov/pubmed/30968060
http://dx.doi.org/10.1093/ofid/ofz142
work_keys_str_mv AT abdullahiadam corrigendumhepatitisbvirushbvinfectionandreactivationduringnucleostidereversetranscriptaseinhibitorsparingantiretroviraltherapyinahighhbvendemicitysetting
AT fopoussiolgamafotsing corrigendumhepatitisbvirushbvinfectionandreactivationduringnucleostidereversetranscriptaseinhibitorsparingantiretroviraltherapyinahighhbvendemicitysetting
AT torimirojudith corrigendumhepatitisbvirushbvinfectionandreactivationduringnucleostidereversetranscriptaseinhibitorsparingantiretroviraltherapyinahighhbvendemicitysetting
AT atkinsmark corrigendumhepatitisbvirushbvinfectionandreactivationduringnucleostidereversetranscriptaseinhibitorsparingantiretroviraltherapyinahighhbvendemicitysetting
AT kouanfackcharles corrigendumhepatitisbvirushbvinfectionandreactivationduringnucleostidereversetranscriptaseinhibitorsparingantiretroviraltherapyinahighhbvendemicitysetting
AT gerettiannamaria corrigendumhepatitisbvirushbvinfectionandreactivationduringnucleostidereversetranscriptaseinhibitorsparingantiretroviraltherapyinahighhbvendemicitysetting